Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Journal of Neuro-Oncology

Volumn 134, Issue 2, 2017, Pages 269-277

  Gittleman, Haley ^a,b   Cote, David J ^c   Ostrom, Quinn T ^a,b   Kruchko, Carol ^b   Smith, Timothy R ^c   Claus, Elizabeth B ^c   Barnholtz Sloan, Jill S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central Brain Tumor Registry of the United States   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain and CNS tumors; Epidemiology; Incidence rates; Non malignant tumors; Racial differences

Indexed keywords

ACOUSTIC NEUROMA; ADOLESCENT; ADULT; AGE; ARTICLE; BLACK PERSON; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CAUCASIAN; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CRANIOPHARYNGIOMA; EPENDYMOMA; GLIOMA; HEMANGIOMA; HUMAN; HYPOPHYSIS TUMOR; INFANT; MAJOR CLINICAL STUDY; MENINGIOMA; NERVE SHEATH TUMOR; NEWBORN; RACE; UNITED STATES; INCIDENCE; PRESCHOOL CHILD; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 85021752893     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-017-2543-4     Document Type: Article

References (34)

1. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–551. doi:10.3171/jns.1998.89.4.0547
2. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF (2002) Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94:1537–1545
3. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG (1999) Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro-oncology 1:14–25
4. Jane JA Jr, Laws ER Jr (2001) The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg 193:651–659
5. Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS (2015) Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro-oncology 17:1166–1173. doi:10.1093/neuonc/nov069
6. Rouse C, Gittleman H, Ostrom QT, Kruchko C, Barnholtz-Sloan JS (2016) Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. Neuro-oncology 18:70–77. doi:10.1093/neuonc/nov249
7. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-oncology 17(Suppl 4):iv1–iv62. doi:10.1093/neuonc/nov189
8. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-oncology 16(Suppl 4):iv1–i63. doi:10.1093/neuonc/nou223
9. Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, Thorsson AV, Carroll PV, Korbonits M, Benediktsson R (2015) The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study. Eur J Endocrinol 173:655–664. doi:10.1530/eje-15-0189
10. Bahemuka M (1988) Worldwide incidence of primary nervous system neoplasms. Geographical, racial and sex differences, 1960–1977. Brain 111(Pt 3):737–755
11. Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377–382. doi:10.1111/j.1365-2265.2009.03667.x
12. Gittleman H, Ostrom QT, Farah PD, Ondracek A, Chen Y, Wolinsky Y, Kruchko C, Singer J, Kshettry VR, Laws ER, Sloan AE, Selman WR, Barnholtz-Sloan JS (2014) Descriptive epidemiology of pituitary tumors in the United States, 2004–2009. J Neurosurg 121:527–535. doi:10.3171/2014.5.jns131819
13. Gruppetta M, Mercieca C, Vassallo J (2013) Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary 16:545–553. doi:10.1007/s11102-012-0454-0
14. Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS (2015) Alex’s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-oncology 16(Suppl 10):x1–x36. doi:10.1093/neuonc/nou327
15. Preston-Martin S, Lewis S, Winkelmann R, Borman B, Auld J, Pearce N (1993) Descriptive epidemiology of primary cancer of the brain, cranial nerves, and cranial meninges in New Zealand, 1948–88. Cancer Causes Control 4:529–538
16. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 18:121–131. doi:10.1158/1055-9965.epi-08-0679
17. DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A (2016) Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin 66:31–42. doi:10.3322/caac.21320
18. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385:977–1010 doi:10.1016/s0140-6736(14)62038-9
19. Haider AH, Scott VK, Rehman KA, Velopulos C, Bentley JM, Cornwell EE 3rd, Al-Refaie W (2013) Racial disparities in surgical care and outcomes in the United States: a comprehensive review of patient, provider, and systemic factors. J Am Coll Surg 216:482–492.e412. doi:10.1016/j.jamcollsurg.2012.11.014
20. Hunt B, Balachandran B (2015) Black:White disparities in lung cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol 39:908–916. doi:10.1016/j.canep.2015.10.003
21. Hunt BR, Whitman S, Hurlbert MS (2014) Increasing Black:White disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol 38:118–123. doi:10.1016/j.canep.2013.09.009
22. Doamekpor LA, Zuckerman DM (2014) Lack of diversity in cancer drug clinical trials may exacerbate racial disparities in mortality rates. Cancer Epidemiol 38:645–646. doi:10.1016/j.canep.2014.06.007
23. Barnholtz-Sloan JS, Maldonado JL, Williams VL, Curry WT, Rodkey EA, Barker FG 2nd, Sloan AE (2007) Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol 85:171–180. doi:10.1007/s11060-007-9405-4
24. Curry WT Jr, Barker FG 2nd (2009) Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol 93:25–39. doi:10.1007/s11060-009-9840-5
25. Curry WT, Jr., Carter BS, Barker FG, 2nd (2010) Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988–2004. Neurosurgery 66:427–437. doi:10.1227/01.neu.0000365265.10141.8e (discussion 437–428)
26. Gittleman HR, Ostrom QT, Rouse CD, Dowling JA, de Blank PM, Kruchko CA, Elder JB, Rosenfeld SS, Selman WR, Sloan AE, Barnholtz-Sloan JS (2015) Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer 121:102–112. doi:10.1002/cncr.29015
27. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-oncology 15(Suppl 2):ii1–i56. doi:10.1093/neuonc/not151
28. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20:E1. doi:10.3171/foc.2006.20.4.E1
29. Jorgensen JT, Johansen MS, Ravnskjaer L, Andersen KK, Brauner EV, Loft S, Ketzel M, Becker T, Brandt J, Hertel O, Andersen ZJ (2016) Long-term exposure to ambient air pollution and incidence of brain tumours: The Danish nurse cohort. Neurotoxicology. doi:10.1016/j.neuro.2016.06.003
30. Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16:562–566
31. Nuno M, Mukherjee D, Elramsisy A, Nosova K, Lad SP, Boakye M, Yu JS, Black KL, Patil CG (2012) Racial and gender disparities and the role of primary tumor type on inpatient outcomes following craniotomy for brain metastases. Ann Surg Oncol 19:2657–2663. doi:10.1245/s10434-012-2353-z
32. Moore SP, Antoni S, Colquhoun A, Healy B, Ellison-Loschmann L, Potter JD, Garvey G, Bray F (2015) Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study. Lancet Oncol 16:1483–1492. doi:10.1016/s1470-2045(15)00232-6
33. Jacobs-Wingo JL, Espey DK, Groom AV, Phillips LE, Haverkamp DS, Stanley SL (2016) Causes and Disparities in Death Rates Among Urban American Indian and Alaska Native Populations, 1999–2009. Am J Public Health 106:906–914. doi:10.2105/ajph.2015.303033
34. Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, Stearns DS, Wolff JE, Liu M, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2016) American brain tumor association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-oncology 18(Suppl 1):i1–i50. doi:10.1093/neuonc/nov297